Application of molecular classification to guiding fertility-sparing therapy for patients with endometrial cancer or endometrial intraepithelial neoplasia.

Zhang, Xiaobo; Chen, Deyi; Zhao, Xiaoya; Wang, Chen; He, Yijiao; Chen, Yan; Wang, Jianliu; Shen, Danhua

Zhang, Xiaobo; Chen, Deyi; Zhao, Xiaoya; Wang, Chen; He, Yijiao; Chen, Yan; Wang, Jianliu; Shen, Danhua.

Affiliation

Zhang X; Department of Pathology, Peking University People's Hospital, Beijing 100044, China.
Chen D; Xiamen Spacegen Co., Ltd, Xiamen 361000, China.
Zhao X; Department of Pathology, Peking University People's Hospital, Beijing 100044, China.
Wang C; Department of Pathology, Peking University People's Hospital, Beijing 100044, China.
He Y; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Chen Y; Xiamen Spacegen Co., Ltd, Xiamen 361000, China.
Wang J; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China. Electronic address: wangjianliu1203@163.com.
Shen D; Department of Pathology, Peking University People's Hospital, Beijing 100044, China. Electronic address: danhuashen@126.com.

Pathol Res Pract ; 241: 154278, 2023 Jan.

Article in En | MEDLINE | ID: mdl-36580798

Subject(s)
Key words

Endometrial atypical hyperplasia; Endometrial endometrioid cancer; Fertility sparing; Molecular classification

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endometrial Neoplasms / Carcinoma, Endometrioid / Endometrial Hyperplasia Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Pathol Res Pract Year: 2023 Document type: Article Affiliation country: China Country of publication: Alemania

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google